Embed Size (px)
Citation preview
This Quarter’s Headline
Biogen and Eisai Agree to Work Together on Alzheimer’sTherapy Aducanumab
October 26, 2017 by JANET STEWART
Collaboration to Evaluate Combination of Nivolumab +Brentuximab Vedotin in Phase III Trial in Relapsed HodgkinLymphoma Expanded
June 2, 2017
FDA Taking New Steps to Better Inform Physicians AboutBiosimilars Through Education About These Potentially Cost-saving Options
October 23, 2017 by FDA Voice
Recommended Services/Products
Single Domain Antibody Services De Novo Antibody Sequencing Service
Most Comprehensive One-stop Services. 100% Coverage, 100% Accuracy
Technical Topic - VideoImmunogenicity Overview of Therapeutic Biologics
The concept of immunogenicity, background and importance ofimmunogenicity therapeutic biologics development are introducedby Creative Biolabs. Watch
New Technical DocumentSingle Domain Antibody Library Construction Protocol
Detailed single domain antibody (sdAb) library construction protocolis described by Creative Biolabs. Immunization schedule and criticalfactors of immunized library construction are summarized in relativesteps. Learn more
Upcoming Meetings in Jan, 2018Immunotherapy WorldJan 23-25, 2018, Miami, United States
PepTalk: The Protein Science WeekJan 8-12, 2018, San Diego, United States
Combined CAR-T Congress EuropeJan 30-31, 2018, Berlin, Germany
45-1 Ramsey Road, Shirley, NY 11967, USA ©Copyright 2019 Creative Biolabs
Tel: 1-631-381-2994 Fax: [email protected] | www.creative-biolabs.com
